- Bjelic- Radisic V, Cardoso F, Weis J....Nookala M...Duhoux F...etal. on behalf of the EORTC Quality of Life Group and Breast Cancer Group (2025). An international Phase IV field study - psychometric properties of the updated module on assessing quality of life of patients with breast cancer EORTC QLQ-BR42. The Breast. PMID: 39947087
- Bajpai J, Sarkar L, Rath S, Chandrasekharan A, Panda G, Jakar D, Pawar A, Ghosh J, Laskar S, Rekhi B, Khanna N, Manjali JJ, Ramadwar M, Purandare N, Bhargava P, Chakrabarty N, Gala K, Kembhavi Y, Rangarajan V, Banavali S, Gupta S (2025). Ten-year follow-up of outcomes, patterns of care, and psychosocial burden in adolescent and young adult (AYA) patients with bone sarcomas from a large cohort in a low-income and middle-income country (LMIC). Cancer. 131(1):e35547 PMID: 39297373
- Chaudhary N, La Ferlita A, Choudhary BS, Jog E, Kazi M, Yahya S, Dalwai A, Ostwal V, Kumar S, Redkar S, Khapare N, Kailaje V, B A, Gera P, Bal M, Verma N, Thorat R, Saklani A, Sehgal L, Dalal SN (2025). Patient-derived Organoids and Xenografts Uncover Therapeutic Vulnerabilities in Colorectal Signet Ring Cell Carcinomas. Clinical Cancer Research. PMID: 39879477.
- Chopra S, Bosse T, Horeweg N, Deodhar K, Menon S, Rafael T, Pai V, Rijstenberg L, Kemenade F, Kannan S, Mahantshetty U, Segedin B, Huang F, Bruheim K, Perez M, Rai B, Tan L, Giannakopoulus N, Schmid M, Tanderup K, Pötter R, Nout R (2025). Biomarker expression and impact on clinical outcomes in an international study of chemoradiation and MRI-based image-guided brachytherapy for locally advanced cervical cancer: BIOEMBRACE. International Journal of Radiation Oncology, Biology, Physics. 121(1): 97-106.PMID: 39067486
- Khanna D, Mishra A, Birur P, Shruti T, Gurushanth K, Mukhia N, Pathak R, Gurmeet Singh A, Shetty A, Pradhan S, Chaturvedi P. A prospective study on diagnostic accuracy of technology-enabled early detection of oral cancer and epidemiology of tobacco and other substances use in rural India. Cancer. 131(1):e35702. PMID: 39748663
- Murthy V, Dal Pra A (2025). Transporting testosterone home: Navigating the road to recovery. European Urology. 87(1): 58-59. PMID: 39472203.
- Mishra GA, Pimple SA, Anand KV, Kulkarni VY, Patil AS, Biswas SK (2025). Acceptability and validity of HPV self-sampling for cervical cancer screening among women living in different ecological settings in India. International Journal of Cancer. 156(6):1142-1153.PMID: 39412108
- Mirgh S, Lall S, Punatar S, Gokarn A, Jindal N, Chichra A, Bhat V, Khattry N (2025). Dirt Under the finger-nails-more malignant than malignancy. American Journal of Hematology.
- Murthy V, Marvaso G, Jereczek-Fossa BA, Thoma SA, Vogel M, Schmidt-Hegemann NS, Shelan M, Siva S, Hoelscher T, Kishan AU, Peeken JC, Gillessen S, Guckenberger M, Herrmann K, Fendler WP, Zilli T, Spohn SKB, Zamboglou C (2025). The Co-IMPACT Consortium: Integrating Prostate-specific Membrane Antigen Positron Emission Tomography and Radiotherapy in Prostate Cancer Care. European Urology. PMID: 39837736.
- Maitre P, Zaorsky N, Dess R, Koontz B, Tree A, Zilli T (2025). Precision over tradition: Transforming prostate cancer treatment with stereotactic radiation therapy. International Journal of Radiation Oncology,Biology Physics. 121(5): 1093-1097.
- Murthy V, Maitre P, Bakshi G, Pal M, Singh M, Sharma R, Gudipudi D, Pujari L, Pandey H, Bandekar B, Joseph D, Krishnatry R, Phurailatpam R, Kannan S, Arora A, Misra A, Joshi A, Noronha V, Prabhash K, Menon S, Prakash G (2024). Bladder Adjuvant RadioTherapy (BART): Acute and late toxicity from a phase III multicentre randomized controlled trial: Acute and late toxicity in BART RCT. International Journal of Radiation Oncology, Biology, Physics. 121(3):728-736. PMID: 39353477
- Noronha V, Menon N, Patil VM, Shah M, Joshi A, Shah S, Nawale K, Surve R, Bafna G, Jogdhankar S, Shelar P, Shetake A, Singh A, Salian S, Jadhav P, Shah H, Mer N, Vohra A, Majumdar S, Banavali S, Badwe R, Prabhash K (2025). Pregabalin for chronic cough due to lung cancer: randomized, double-blind, placebo-controlled trial. British Journal of Cancer.132(1):58-68. PMID: 39592738.
- Rajendra A, Sengar M, Korula A, Ganesan P, Jain H, Divya K, Samuel P, Perumal Kalaiyarasi J, Prakash G, John MJ, Palassery R, Nair CK, Shet T, Selvarajan S, Nayak L, Karunakaran P, Fouzia NA, Prakash O, Bagal B, Mehra N, Kumaran S, Epari S, Thorat J, Radhakrishnan V, Abraham A (2025). Outcomes and prognostic factors in patients with Burkitt lymphoma/leukemia in adolescents and adults: an experience from hematology cancer consortium. Blood Cancer Journal. 15(1):38.
- Raj J, Shah J, Ghanekar S, John G, Goda JS, Chatterjee A (2025). Pharmacological and therapeutic innovation to mitigate Radiation-Induced Cognitive Decline (RICD) in brain tumor Patients. Cancer Letters.
- Singh M, Katdare A, Ghosh S, Choudhury S, Phurailatpam R, Patil D, Tiwari M, Anaz M, Chougle N, Sable N, Agrawal A, Pawar A, Rangarajan V, Maitre P, Murthy V (2025). PSMA-PET guided Intra-prostatic Boost in Prostate SBRT (PROBE): A phase II trial. International Journal of Radiation Oncology,Biology, Physics.
- Bajpai J, Kapau V, Rath S, Kumar S, Sekar A, Patil P, Siddiqui A, Anne S, Pawar A, Srinivas S, Bhargava P, Gulia S, Noronha V, Joshi A, Prabhash K, Banavali S, Sarin R, Badwe R, Gupta S (2024). Low-dose versus standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting in patients with solid tumours: a single-centre, open-label, non-inferiority, randomised, controlled, phase 3 trial. The Lancet Oncology. 25(2): 246-254.PMID: 38224701
- Roy Moulik N, Keerthivasagam S, Pandey A, Agiwale J, Hegde K, Chatterjee G, Dhamne C, Prasad M, Chichra A, Srinivasan S, Mohanty P, Jain H, Shetty D, Tembhare P, Patkar N, Narula G, Subramanian PG, Banavali S (2024). Treatment and follow-up of children with chronic myeloid leukaemia in chronic phase (CML-CP) in the tyrosine kinase inhibitor (TKI) era-Two decades of experience from the Tata Memorial Hospital paediatric CML (pCML) cohort. British Journal of Haematology. 204(4):1249-1261. PMID: 38098201
- Ramaswamy A, Bhargava P, Srinivas S, Kapoor A, Mishra BK, Gupta A, Mandavkar S, Kannan S, Chaugule D, Patil R, Parulekar M, Nashikkar C, Ankathi SK, Kaushal RK, Naughane D, Daddi A, Mer N, Shetty N, Ostwal V (2024). Bevacizumab erlotinib switch maintenance in chemo-responsive advanced gallbladder and cholangiocarcinoma (BEER BTC): A multicenter, open-label, randomized, phase II trial. Journal of Clinical Oncology. PMID: 39102628
- Singh M, Maitre P, Krishnan A, Adsul K, Sarath MS, Chauhan H, Bishnu P, Phurailatpam R, Singh P, Kamble D, Bakshi G, Pal M, Arora A, Misra A, Prakash G, Murthy V (2024). Late urinary toxicity after extreme or moderate hypofractionated prostate radiotherapy in patients with prior transurethral resection of prostate (TURP). International Journal of Radiation Oncology, Biology,Physics.
- Sandhbhor P, Palkar P, Bhat P, Bhat S, John G, Goda J (2024). Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy. Nanoscale. 16(13):6330-6364. PMID: 38470224
- Varghese R, Pal K, Gota V, Islam MF (2024). Colonic probiotic insufflation: clinical proposal for an economical game-changer for restoration of the gut microbiome in colorectal cancer and beyond. International Journal of Surgery. 110(5): 2515-2519. PMID: 38348859
- Wilson BE, Booth CM, Suvillian R, Aggarwal A, Sengar M, Jacob S, Bray F, Barton MB, Pearson S-A (2023).Global application of National Comprehensive Cancer Network resource-stratified guidelines for systemic treatment of colon cancer: a population-based, customisable model for cost, demand, and procurement. Lancet Oncology. 24(6): 682-690. PMID: 37269845
- Verghese G, Lennerz JK, Ruta D, Ng W, Thavaraj S, Siziopikou KP, Naidoo T, Rane S, Salgado R, Pinder SE, Grigoriadis A (2023). Computational pathology in cancer diagnosis, prognosis, and prediction - present day and prospects. Journal of Pathology.260(5):551-563. PMID: 37580849
- Vesprini D, Pathmanathan A, Murthy V. Elective nodal irradiation: Old game, new sport. International Journal of Radiation Oncology,Biology,Physics. 17(3): 610-612.PMID: 37739608
- Venkatesulu B, Liauw SL, Joshi M, Brian Baumann B, Yoo R, Roupret M, Choudhury A, Efstathiou J, Murthy V, Sargos P, Solanki A (2023). Multidisciplinary management and radiotherapy recommendations for clinically and pathologically node-positive bladder cancer. Seminars in Radiation Oncology. 33 (1): 35-50. PMID: 36517192.
- Barrios C, de Lima Lopes G, Yusof MM, Rubagumya F, Rutkowski P, Sengar M (2023). Barriers in access to oncology drugs - a global crisis. Nature Reviews Clinical Oncology. 20(1):7-15. PMID: 36380066
- Budrukkar A, Murthy V, Kashid S, Swain M, Rangarajan V, Ghosh-Laskar S, Kannan S, Kale S, Upreti R, Pai P, Pantvaidya G, Gupta T, Agarwal JP (2023). Intensity Modulated Radiation Therapy Alone Vs Intensity modulated radiation therapy and brachytherapy for T1-T2N0M0 oropharyngeal cancers: Results from A randomized controlled trial. International Journal of Radiation Oncology, Biology, Physics. S0360-3016(23)07854-9. PMID: 37660737
- Yadav S, Mittal N, Rane SU, Bal M, Patil A, Ankathi SK, Nair D. Nonsalivary Primary Adenocarcinomas of the Base of Tongue. Arch Pathol Lab Med. 2023 PMID: 36602895.
- Schmid MP, Lindegaard JC, Mahantshetty U, Tanderup K, Jürgenliemk-Schulz I, Haie-Meder C, Fokdal LU, Sturdza A, Hoskin P, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Petric P, Ramazanova D, Ristl R, Kannan S, Hawaldar R, Ecker S, Kirchheiner K, Tan LT, Nout R, Nesvacil N, de Leeuw A, Pötter R, Kirisits C; EMBRACE Collaborative Group (2023). Risk factors for local failure following chemoradiation and magnetic resonance image-guided brachytherapy in locally advanced cervical cancer: Results from the EMBRACE-I Study. Journal of Clinical Oncology. PMID: 36599120
- Soerjomataram I, Cabasag C, Bardot A, Fidler-Benaoudia M, Miranda-Filho A, Ferlay J, Parkin D, Ranganathan R, Piñeros M, Znaor A, Mery L, Joko-Fru Y, Dikshit R, Sankaranarayanan R, Swaminathan R, Bray F (2023).Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries. Lancet Oncology. 24 (1): 22-32. PMID: 36603919
- Spohn S, Draulans C, Kishan A, Spratt D, Ross A, Maurer T, Tilki D, Berlin A, Blanchard P, Collins S, Bronsert P, Chen R, Pra A, Meerleer G, Eade T, Haustermans K, Hölscher T, Höcht S, Ghadjar P, Davicioni E, Heck M, Kerkmeijer L, Kirste S, Tselis N, Tran P, Pinkawa M, Pommier P, Deltas C, Schmidt-Hegemann N, Wiegel T, Zilli T, Tree A, Qiu X, Murthy V, Epstein J, Graztke C, Gao X, Grosu A, Kamran S, Zamboglou C (2023). Genomic classifiers in personalized prostate cancer radiotherapy approaches – A systematic review and future perspectives based on international consensus. International Journal of Radiation Oncology, Biology Physics. 116(3):503-520.PMID: 36596346
- Leung K, McLeod M, Torode J, Ilbawi A, Chakowa J, Bourbeau B, Sengar M, Booth CM, Gralow JR, Sullivan R, Aggarwal A(2023). Quality indicators for systemic anticancer therapy services: a systematic review of metrics used to compare quality across healthcare facilities. European Journal of Cancer. 195:113389. PMID: 37924649.
- Laskar SG, Chaukar D, Deshpande M, Chatterjee A, Sinha S, Chakraborty S, Agarwal JP, Gupta T, Budrukkar A, Murthy V, Pai P, Chaturvedi P, Pantvaidya G, Deshmukh A, Nair D, Nair S, Prabhash K, Swain M, Kumar A, Noronha V, Patil V, Joshi A, DCruz A. Oral cavity adjuvant therapy (OCAT) -a phase III, randomized controlled trial of surgery followed by conventional RT (5 fr/wk) versus concurrent CT-RT versus accelerated RT (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavity. European Journal of Cancer. 181:179-187. PMID: 36669426.
- Pramesh CS, Sengar M, Patankar S, Chinnaswamy G, Gupta S, Vijayakumar M, Sood S, Sathe AN, Radhakrishnan V, Ganesan P, Mallavarapu KM, Badwe RA. A National Cancer Grid pooled procurement initiative, India. Bulletin of World Health Organization. 101(9):587-594. PMID: 37638358;
- Harkenrider M, Fields E, Chopra S, Damast S, Kidd E, Chino J (2023). Recent key Studies in cancers of the uterine corpus and cervix: New updates in immunotherapy, the microbiome, bone density, quantifying lymphovascular invasion, and hypofractionated pelvic radiation therapy. International Journal of Radiation Oncology Biology Physics. 115(2): 269-275. PMID: 36621226
- Chatterjee G, Patkar N (2023). United we stand, divided we fall. Multicentre standardization of measurable residual disease assessment in acute leukaemia is the way forward. British Journal of Haematology. 200(3):277-279 PMID: 36282207
- Ghosh Laskar S, Chaukar D, Deshpande M, Chatterjee A, Sinha S, Chakraborty S, Agarwal JP, Gupta T, Budrukkar A, Murthy V, Pai P, Chaturvedi P, Pantvaidya G, Deshmukh A, Nair D, Nair S, Prabhash K, Swain M, Kumar A, Noronha V, Patil V, Joshi A, D'Cruz A (2023). Oral Cavity Adjuvant Therapy (OCAT) -A phase III, randomized controlled trial of surgery followed by conventional RT (5 fr/wk) vs concurrent CT-RT vs accelerated RT (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavity. European Journal of Cancer. 181 :179-187
- Fields E, Chopra S, Ludwig M, Taunk N, Chino J (2023). Pivotal science from the 2022 International Gynecologic Cancer Society Meeting. International Journal of Radiation Oncology, Biology, Physics. 116(3): 473-478.
- Bagal B, Sarma R, Dey S, Nayak L, Bonda A, Goda J, Khanna N, Dasgupta A, Kakoti S, Chatarjee A, Jain H, Epari S, Laskar S, Sengar M, Gupta T (2023). Lenalidomide following whole-brain radiotherapy in patients with primary central nervous system lymphoma ineligible for intensive systemic therapy. Br J Haematol. PMID: 36682363.
- Patil VM, Noronha V, Menon N, Rai R, Bhattacharjee A, Singh A, Nawale K, Jogdhankar S, Tambe R, Dhumal S, Sawant R, Alone M, Karla D, Peelay Z, Pathak S, Balaji A, Kumar S, Purandare N, Agarwal A, Puranik A, Mahajan A, Janu A, Kumar Singh G, Mittal N, Yadav S, Banavali S, Prabhash K(2023). Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study. Journal of Clinical Oncology. 41(2):222-232.PMID: 36265101
- Spampinato S, Tanderup K, Lindegaard JC, Schmid MP, Sturdza A, Segedin B, Jürgenliemk-Schulz IM, De Leeuw A, Bruheim K, Mahantshetty U, Chargari C, Rai B, Cooper R, van der Steen-Banasik E, Sundset M, Wiebe E, Villafranca E, Van Limbergen E, Pieters BR, Tee Tan L, C H W Lutgens L, Hoskin P, Smet S, Pötter R, Nout R, Chopra S, Kirchheiner K EMBRACE Collaborative Group (2023) Appendix. Association of persistent morbidity after radiotherapy with quality of life in locally advanced cervical cancer survivors. Radiotheray and Oncology. PMID: 36720348.
- Sengar M, Jain H, Shet T, Sridhar E, Gota V, Rangarajan V, Laskar SS, Alahari A, Thorat J, Agarwal A, Sharma N, Gupta H, Kannan S, Kumar S, Nayak L, Menon H, Gujral S, Bagal B (2023). Phase II trial of a novel chemotherapy regimen CVEP (cyclophosphamide, vinblastine, etoposide and prednisolone) for acquired immunodeficiency syndrome (AIDS)-associated lymphomas. British Journal of Haematology. 200(4):429-439. PMID: 36323643.
- Gokarn A, Shenoy R, Punatar S, Mirgh S, Chichra A, Nayak L, Bonda A, Jindal N, Saroha M, Toshniwal A, Prayag P, Tripathi R, Kumar S, Bhat V, Biswas S, Khattry N (2023). Efficacy of artesunate for treatment of cytomegalovirus reactivation post allogeneic haematopoietic stem cell transplants. Bone Marrow Transplantation. 58(2):209-211 PMID: 36310244.
- Ecker S, Kirisits C, Schmid M, De Leeuw AAC, Seppenwoolde Y, Knoth J, Trnkova P, Heilemann G, Sturdza A, Kirchheiner K, Spampinato S, Serban M, Jürgenliemk-Schulz IM, Chopra S, Nout R, Tanderup K, P¨otter R, Eder-Nesvacil N (2023). Tools for large-scale data analytics of an international multi-center study in radiation oncology for cervical cancer. Radiotherapy and Oncology. PMID: 36764459
- Gokarn A, Shenoy R, Punatar S, Mirgh S, Chichra A, Nayak L, Bonda A, Jindal N, Saroha M, Toshniwal A, Prayag P, Tripathi R, Kumar S, Bhat V, Biswas S, Khattry N (2023). Efficacy of artesunate for treatment of cytomegalovirus reactivation post allogeneic haematopoietic stem cell transplants. Bone Marrow Transplantation. 58(2):209-211 PMID: 36310244.
- Priyadharshn Selvarajan JM, Epari S, Sahu A, Dasgupta A, Chatterjee A, Gupta T (2023) . Pearls & Oy-sters: Primary diffuse leptomeningeal melanocytosis: A diagnostic conundrum. Neurology. PMID: 36878703
- Ramaswamy A, Shah D, Bhargava P, Srinivas S, Kannan S, Shah M, Suman M, Das S, Trikha M, Ostwal V. Modified FOLFIRINOX compared to Gemcitabine & nab-Paclitaxel in advanced pancreatic ductal adenocarcinoma - results of a match-pair analysis. Indian Journal of Medical Research. 157(1):57-65. PMID: 37040228.
- Jha AK, Mthun S, Sherkhane U, Jaiswar V, Osong B, Purandare N, Kannan S, Prabhash K, Gupta S, Vanneste B, Rangarajan V, Dekker A, Wee L (2023). Systematic review and meta-analysis of prediction models used in cervical cancer.Artificial Intelligence in Medicine
- Singh C, Yanamandra U, Karunakaran P, Jindal N, Kumar SR, Saini N, Jandial A, Jain A, Das C, Lad D, Prakash G, Khadwal A, Naseem S, Das R, Varma N, Varma S, Malhotra P (2023). Long-term real-world outcomes of patients with acute promyelocytic leukaemia treated with arsenic trioxide and all-trans retinoic acid without chemotherapy-a retrospective, single-centre study. British Journal of Haematology. 201(2):249-255. PMID: 36529704.
- Kumar Gupta S, Gohil D, Dutta D, Panigrahi GC, Gupta P, Dalvi K, Khanka T, Yadav S, Kumar Kaushal R, Chichra A, Punatar S, Gokarn A, Mirgh S, Jindal N, Nayak L, Tembhare PR, Khizer Hasan S, Kumar Sandur S, Hingorani L, Khattry N, Gota V. Withaferin-A alleviates acute graft versus host disease without compromising graft versus leukemia effect. International Immunopharmacology. 121:110437. PMID: 37311352
- Gupta SK, Gohil D, Dutta D, Panigrahi GC, Gupta P, Dalvi K, Khanka T, Yadav S, Kaushal RK, Chichra A, Punatar S, Gokarn A, Mirgh S, Jindal N, Nayak L, Tembhare PR, Hasan SK, Sandur SK, Hingorani L, Khattry N, Gota V (2023). Withaferin-A alleviates acute graft versus host disease without compromising graft versus leukemia effect. International Immunopharmacology. 121: 110437. PMID: 37311352.
- Badwe RA, Parmar V, Nair N, Joshi S, Hawaldar R, Pawar S, Kadayaprath G, Borthakur BB, Rao Thammineedi S, Pandya S, Balasubramanian S, Chitale PV, Neve R, Harris C, Srivastava A, Siddique S, Vanmali VJ, Dewade A, Gaikwad V, Gupta S (2023). Effect of Peritumoral Infiltration of Local Anesthetic Before Surgery on Survival in Early Breast Cancer. Journal of Clinical Oncology. PMID: 37023374.
- Poon D, Yuan J, Yang B, Kerkmeijer L, Kishan A, Murthy V, Zapaetero A, Wong O (2023). Magnetic resonance imaging–guided focal boost to intraprostatic lesions using external beam radiotherapy for localized prostate cancer: A systematic review and meta-analysis. European Urology Oncology. 6 (2): 116-127.
- Verghese G, Li M, Liu F, Lohan A, Kurian NC, Meena S, Gazinska P, Shah A, Oozeer A, Chan T, Opdam M, Linn S, Gillett C, Alberts E, Hardiman T, Jones S, Thavaraj S, Jones JL, Salgado R, Pinder SE, Rane S, Sethi A, Grigoriadis A (2023). Multiscale deep learning framework captures systemic immune features in lymph nodes predictive of triple negative breast cancer outcome in large-scale studies. Journal of Pathology.
- Abraham G, Noronha V, Rajappa S, Agarwal A, Batra U, Somani N, Raja T, Patil S, Kaushal AM, Joshi A, Radhakrishnan V, Singh N, Babu K G, Tewani R, Baghmar S, Dodagoudar C, Ananthakrishnan R, H P S, Sharma V, Menon N, Patil V, Joshi A, Gupta S, Prabhash K, Bajpai J (2022). The clinical utility and safety of Short-course Immune check point inhibitors (ICI) in multiple tumors - A real world multicentric study from India. International Journal of Cancer. 150(6):1045-1052. PMID: 34751432.
- Alaggio R, Amador C, Anagnostopoulos I,... Laskar S, Tembhare P. et al.(2022). The 5th edition of the World Health Organization classification of haematolymphoid tumours: Lymphoid neoplasms. Leukemia. 36(7):1720-1748. PMID: 35732829
- Asija S, Chatterjee A, Yadav S, Chekuri G, Karulkar A, Jaiswal AK, Goda JS, Purwar R (2022). Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds. International Reviews of Immunology. 41(6):582-605. PMID: 35938932
- Barrios C, de Lima Lopes G, Yusof MM, Rubagumya F, Rutkowski P, Sengar M (2022). Barriers in access to oncology drugs - A global crisis. Nature Reviews Clinical Oncology. PMID: 36380066.
- Bhardwaj P, Gota V, Vishwakarma K, Pai V, Chaudhari P, Mohanty B, Thorat R, Yadav S, Gurjar M, Goda JS, Banerjee R. (2022) Loco-regional radiosensitizing nanoparticles-in-gel augments head and neck cancer chemoradiotherapy. Journal of Controlled Release. 343:288-302. PMID: 35101477.
- Chargari C, Arbyn M, Leary A, Abu-Rustum NR, Basu P, Bray F,Chopra S, Nout R, Tanderup K, Viswanathan A, Zacharipoulou C, Soria JC, Deutsch E, Gouy S, Morice P (2022). Increasing global accessibility to high-level treatments for cervical cancers. Gynecologic Oncology. 164(1):231-241. PMID: 34716024
- Chatterjee A, Asija S, Yadav S, Purwar R, Goda JS (2022). Clinical utility of CAR T cell therapy in brain tumors: Lessons learned from the past, current evidence and the future stakes. International Reviews of Immunology.41(6):606-624.PMID: 36191126
- Chatterjee G, Sriram H, Ghogale S, Deshpande N, Khanka T, Girase K, Verma S, Arolkar G, Dasgupta N, Narula G, Shetty D, Dhamne C, Moulik NR, Rajpal S, Patkar NV, Banavali S, Gujral S, Subramanian PG, Tembhare PR (2022). Mimics and artefacts of measurable residual disease in a highly sensitive multicolour flow cytometry assay for B-lymphoblastic leukaemia/lymphoma: critical consideration for analysis of measurable residual disease. British Journal of Haematology. 196(2): 374-379. PMID: 34476808.
- Chopade P, Chopra S, Jain J, Panda S, Patil A, Patil G, Mahantshetty U, Engineer R, Gurram L, Mittal P, Ghosh J, Gupta S, Shrivastava K (2022). Serial bone density changes in women undergoing pelvic (chemo) radiation: Results from PARCER trial. International Journal of Radiation Oncology, Biology, Physics. 114(3):463-471. PMID: 35870710
- Chopade P, Maitre P, David S, Panigrahi G, Singh P, Phurailtpam R, Murthy V (2022).Common iliac node positive prostate cancer treated with curative radiotherapy: N1 or M1a? International Journal of Radiation Oncology, Biology Physics. 114(4):711-717. PMID: 35870708
- Chopra S, Kalra B, Mulani J, Jain J, Gurram L, Mittal P, Alone M, Ghosh J, Rath S, Gulia S, Gupta S (2022). Salvage (re) radiation in oligometastatic and oligorecurrent cervical cancer. International Journal of Radiation Oncology, Biology, Physics. 114(4):812-819. PMID: 35850364.
- Chopra S, Ranjan N, Charnalia M, Kannan S, Engineer R, Dora T, Gurram P, Maheshwari A, Shylasree TS, Shrivastava S, Gupta S (2022). Late toxicity within a Phase III clinical trial of IG-IMRT in cervix cancer (PARCER): Reanalysis with time weighted adverse event reporting (MOSES). Radiotherapy and Oncology. 177:16-20. PMID: 36270474
- Dev ID, Puranik AD, Rangarajan V, Gupta T, Purandare NC, Agrawal A, Shah S. (2022) Radiation-Induced Meningioma in a Case of Medulloblastoma Treated 11 Years Ago-Detected on 68Ga-DOTANOC PET/CT. Clinical Nuclear Medicine. 1; 47 (1):e108-e110. PMID: 34183498.
- Spohn S, Draulans C, Kishan A, Spratt D, Ross A, Maurer T, Tilki D, Berlin A, Blanchard P, Collins S, Bronsert P, Chen R, Pra A, Meerleer G, Eade T, Haustermans K, Hölscher T, Höcht S, Ghadjar P, Davicioni E, Heck M, Kerkmeijer L, Kirste S, Tselis N, Tran P, Pinkawa M, Pommier P, Deltas C, Schmidt-Hegemann N, Wiegel T, Zilli T, Tree A, Qiu X, Murthy V, Epstein J, Graztke C, Gao X, Grosu A, Kamran S, Zamboglou C (2022). Genomic classifiers in personalized prostate cancer radiotherapy approaches – A systematic review and future perspectives based on international consensus. International Journal of Radiation Oncology, Biology Physics. PMID: 36596346
- Gillessen S, Armstrong A, Attard G... Murthy V. et al. Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021. European Urology. 82(1):115-141. PMID: 35450732.
- Gokarn A, Shenoy R, Punatar S, Mirgh S, Chichra A, Nayak L, Bonda A, Jindal N, Saroha M, Toshniwal A, Prayag P, Tripathi R, Kumar S, Bhat V, Biswas S, Khattry N (2022). Efficacy of artesunate for treatment of cytomegalovirus reactivation post allogeneic haematopoietic stem cell transplants. Bone Marrow Transplantation. PMID: 36310244.
- Gupta T, Thakkar P, Kalra B, Kannan S (2021). Hydroxychloroquine in the treatment of coronavirus disease 2019: Rapid updated systematic review and meta-analysis. Reviews in Medical Virology. 32(2):e2276 PMID: 34245622.
- Gupta T, Maheshwari G, Kannan S, Nair S, Chaturvedi P, Agarwal J. Systematic review and meta-analysis of randomized controlled trials comparing elective neck dissection versus sentinel lymph node biopsy in early-stage clinically node-negative oral and/or oropharyngeal squamous cell carcinoma: Evidence-base for practice and implications for research. Oral Oncology. 124: 105642. PMID: 34861565
- Gupta T, Maheshwari G, Kannan S, Nair S, Agarwal JP (2022). Should Sentinel Lymph Node Biopsy Be Considered the New Standard of Care for Early-Stage Clinically Node-Negative Oral Squamous Cell Carcinoma? Journal of Clinical Oncology. 40(15):1706-1709. PMID: 35298298.
- Gupta T, Pervez S, Dasgupta A, Chatterjee A, Epari S, Chinnaswamy G, Jalali R (2022). Omission of upfront craniospinal irradiation in patients with low-risk WNT-pathway medulloblastoma is associated with unacceptably high risk of neuraxial failure. Clinical Cancer Research. 28(19):4180-4185. PMID: 35653134
- Gupta T, Kannan S, Ghosh-Laskar S, Agarwal JP (2022). Concurrent chemoradiotherapy with cisplatin given once-a-week versus every-three weekly in head and neck squamous cell carcinoma: Non-inferior, equivalent, or superior? Oral Oncology. 134: 106130. PMID: 36162191
- Hande V, Chopra S, Kalra B, Abdel-Wahab M, Kannan S, Tanderup K, Grover S, Zubizarreta E, Rubio JAP. Point-A vs (2022). Volume-based brachytherapy for the treatment of cervix cancer: A meta-analysis. Radiotheray Oncology. 170:70-78. PMID: 35259419.
- Horeweg N, Mittal P, Gradowska PL, Boere I, Nout RA, Chopra S. A systematic review and meta-analysis of adjuvant chemotherapy after chemoradiation for locally advanced cervical cancer. Critical Reviews in Oncology/ Hematology. 172: 103638 PMID: 35189325.
- Khoury JD, Solary E, Abla O ,... Patkar N, Picarsic J, Platzbecker U, Roberts I, Schuh A, Sewell W, Siebert R, Tembhare P, Khattry N, Subramanian PG. et al. (2022). The 5th edition of the World Health Organization classification of haematolymphoid tumours: Myeloid and histiocytic/dendritic neoplasms. Leukemia. PMID: 35732831.
- Kumar R, Abreu C, Toi M, Saini S, Casimiro S, Arora A, Paul AM, Velaga R, Rameshwar P, Lipton A, Gupta S, Costa L. Oncobiology and treatment of breast cancer in young women. Cancer Metastasis Reviews. 41(3):749-770. PMID: 35488982.
- Laskar S, Sinha S, Chatterjee A, Khanna N, Manjali JM, Puri A, Gulia A, Nayak P, Vora T, Chinnaswamy G, Prasad M, Bajpai J, Juvekar S, Desai S, Janu A, Rangarajan V, Purandare N, Shah S, Rekhi B, Jambhekar N, Muckaden M, Kurkure P (2022). Radiotherapy dose escalation in unresectable Ewing's sarcoma: Final results of a phase III randomized controlled trial. International Journal of Radiation Oncology,Biology,Physics. PMID: 35568246
- Laskar SG, Sinha S, Pai DP, Nair D, Budrukkar A, Swain M, Kimar A, Moiyadi A, Shetty P, Roy V, Johnny C, Murthy V, Gupta T, Menon N, Patil V, Noronha V, Joshi A, Prabhash K, Agarwal JP (2022). Definitive and adjuvant radiation therapy for external auditory canal and temporal bone squamous cell carcinomas: Long term outcomes. Radiotherapy Oncology. 170: 151–158. PMID: 35219800.
- Maitre P, Sood S, Pathare P, Krishnatry R, Agarwal A, Rangarajan V, Murthy V (2022). Timing of Ga68-PSMA PETCT and patterns of recurrence after prostate radiotherapy: Implications for potential salvage. Radiotherapy Oncology. 169: 71-76.PMID: 35189154.
- Mittal P, Chopra S, Charnalia M, Dora T, Engineer R, Mulani J, Scaria L, Prajapati K, Kannan S, Gurram L, Mahantshetty U, Gupta S, Shrivastava SK. Patterns of Relapse After Adjuvant Chemoradiation for Cervical Cancer in a Phase 3 Clinical Trial (PARCER): An Evaluation of Updated NRG Oncology/RTOG Target Delineation Guidelines. International Journal of Radiation Oncology Biology Physics. 113(2):369-378.PMID: 35157993.
- Murthy V, Adsul K, Maitre P, Singhla A, Singh P, Panigrahi G, Raveendran V, Phurailatpam R (2022). Acute and late toxicity of prostate-only or pelvic SBRT in prostate cancer: A Comparative study. International Journal of Radiation Oncology,Biology,Physics. 114(2):275-282. PMID: 35724773
- Patil V, Noronha V, Joshi A, Menon N, Mathrudev V, Bhattacharjee A, Chandrasekharan A, Vallathol D, Dsouza H, Srinivas S, Mandal T, Chaturvedi P, Chaukar D, Pai P, Nair S, Thiagrajan S, Laskar S, Nawale K, Babanrao Dhumal S, Tambe R, Banavali S, Prabhash K. RMAC study: A randomized study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiation. Oral Oncology.128: 105816. PMID: 35367787.
- Patil VM, Noronha V, Menon N, Rai R, Bhattacharjee A, Singh A, Nawale K, Jogdhankar S, Tambe R, Dhumal S, Sawant R, Alone M, Karla D, Peelay Z, Pathak S, Balaji A, Kumar S, Purandare N, Agarwal A, Puranik A, Mahajan A, Janu A, Kumar Singh G, Mittal N, Yadav S, Banavali S, Prabhash K. Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study. Journal of Clinical Oncology.PMID: 36265101
- Pramesh CS, Badwe RA, Bhoo-Pathy N, Booth CM, Chinnaswamy G, Dare AJ, de Andrade VP, Hunter DJ, Gopal S, Gospodarowicz M, Gunasekera S, Ilbawi A, Kapambwe S, Kingham P, Kutluk T, Lamichhane N, Mutebi M, Orem J, Parham G, Ranganathan P, Sengar M, Sullivan R, Swaminathan S, Tannock IF, Tomar V, Vanderpuye V, Varghese C, Weiderpass E. Priorities for cancer research in low- and middle-income countries: a global perspective. Nature Medicine. 28(4):649-657. PMID: 35440716.
- Sawhney S, Thiagarajan S, Balaji A, Sathe P, Jain S, Rukmangathan TM, Kannan S, Shah S, Chaukar D.(2022) Results of sequential swallowing assessments in patients undergoing upfront surgery for oral tongue squamous cell carcinoma.Oral Oncology. 125:105684. PMID: 34963096
- Sengar M, Jain H, Shet T, Sridhar E, Gota V, Rangarajan V, Laskar SS, Alahari A, Thorat J, Agarwal A, Sharma N, Gupta H, Kannan S, Kumar S, Nayak L, Menon H, Gujral S, Bagal B (2022). Phase II trial of a novel chemotherapy regimen CVEP (cyclophosphamide, vinblastine, etoposide and prednisolone) for acquired immunodeficiency syndrome (AIDS)-associated lymphomas. British Journal of Haematology. PMID: 36323643.
- Spampinato AS Jensen N, Pötter R, Fokdal L, Chargari C, Lindegaard J, Schmid M, Sturdza A, Ina M. Schulz J, Mahantshetty U, Hoskin P, Segedin B, Rai B, Bruheim K, Wiebe E, Steen-Banasik E, Cooper R, Limbergen E, Sundset M, Pieters B, Lutgens L, Tan L, Villafranca E, Smet S, Jastaniyah N, Nout R, Kirisits C, Chopra S, Kirchheiner K, Tanderup K (2022). EMBRACE Collaborative Group. Severity and persistency of late gastrointestinal morbidity in locally advanced cervical cancer: lessons learned from EMBRACE-I and implications for the future. International Journal of Radiation Oncology Biology Physics. 112(3):681-693.PMID: 34678431
- Tembhare PR, Sriram HN, Chatterjee G, Khanka T, Gokarn A, Mirgh S, Rajendra A, Chaturvedi A, Ghogale SG, Deshpande N, Girase K, Dalvi K, Rajpal S, Patkar N, Trivedi B, Joshi A, Murthy V, Shetty N, Nair S, More A, Kamtalwar S, Chavan P, Bhat V, Bhat P, Subramanian PG, Gupta S, Khattry N (2022). Comprehensive immune cell profiling depicts an early immune response associated with severe COVID-19 disease in cancer patients. Immunology and Cell Biology. 100(1):61-73. PMID: 34582592.
- Turco F, Armstrong A, Attard G... Murthy V. et al. (2022). What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021. European Urology. 82(1):6-11. PMID: 35393158
- Bhardwaj P, Goda JS, Pai V, Chaudhari P, Mohanty B, Pai T, Vishwakarma K, Thorat R, Wadasadawala T, Banerjee R (2021). Ultrasound augments on-demand breast tumor radiosensitization and apoptosis through a tri-responsive combinatorial delivery theranostic platform. Nanoscale. 13(40):17077-17092.PMID: 34622906
- Anand D, Yashashwi K, Kumar N, Rane S, Gann PH, Sethi A (2021). Weakly supervised learning on unannotated hematoxylin and eosin stained slides predicts BRAF mutation in thyroid cancer with high accuracy. Journal of Pathology.255(3):232-242 PMID: 34346511
- Chilukuri S, Murthy V(2021) . Adjuvant radiation for prostate cancer: Too early to abandon? BJU International. 128(1):23-24. PMID: 33834591
- Chopra S, Gupta S, Kannan S, Dora T, Engineer R, Mangaj A, Maheshwari A, Shylasree TS, Ghosh J, Paul SN, Phurailatpam R, Charnalia M, Alone M, Swamidas J, Mahantshetty U, Deodhar K, Kerkar R, Shrivastava SK (2021). Late Toxicity After Adjuvant Conventional Radiation Versus Image-Guided Intensity-Modulated Radiotherapy for Cervical Cancer (PARCER): A Randomized Controlled Trial. Journal of Clinical Oncology. 39(33):3682-3692. PMID: 34506246.
- Chopra S, Mangaj A, Sharma A, Tan LT, Sturdza A, Schulz I, Han K, Huang F, Schmid M, Fokdal L, Chargari C, Diendorfer T, Tanderup K, Potter R, Nout R (2021). Management of oligo-metastatic and oligo-recurrent cervical cancer: A pattern of care survey within the EMBRACE research network 155: 151-159. Radiotherapy and Oncology. PMID: 33144247
- Damast S, Fields E, Kidd E, Harkenrider M, Chopra S, Chino J (2021). Reports from Four International Clinical Trials for Cancers of the Cervix, Uterus and Vulva, and a New Guideline for Cervical Cancer. International Journal of Radiation Oncology Biology Physics. 111(2):299-306. PMID: 34473967
- Fundytus A, Sengar M, Lombe D, Hopman W, Jalink M, Gyawali B, Trapani D, Roitberg F, De Vries EGE, Moja L, Ilbawi A, Sullivan R, Booth CM (2021). Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey. Lancet Oncology. 22(10):1367-1377. PMID: 34560006
- Gandhi V, Gandhi K, Kumbhare L, Goda J, Gota V, Priyadarsini K, Kunwar A (2021). 3,3′-diselenodipropionic acid (DSePA) induces reductive stress in A549 cells triggering p53-independent apoptosis: A novel mechanism for diselenides. Free Radical Biology and Medicine. 175: 1-17. PMID: 34425189
- Ganesan P, Jain H, Bagal B, Subramanian PG, George B, Korula A, Mehra N, Kalaiyarasi JP, Bhurani D, Agrawal N, Ahmed R, Kayal S, Bhattacharyya J, Yanamandra U, Kumar S, Philip CC, John MJ, Nadaraj A, Karunamurthy O, Lakshmanan J, Mathews V, Sengar M (2021). Outcomes in adolescent and young adult acute lymphoblastic leukaemia: A report from the Indian Acute Leukaemia Research Database (INwARD) of the Hematology Cancer Consortium (HCC). British Journal of Haematology. 193: e1-e8. PMID: 33656752
- Glasbey J, Ademuyiwa A....Moiyadi A....etal;COVID Surge Colloborative. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. Lancet Oncology. 22(11): 1507-1517. PMID: 34624250
- Gulia S, Gupta S (2021). Subgroup Analysis from SOLO1 Trial. Journal of Clinical Oncology. 39(3):255. PMID: 33326258
- Gupta T, Manjali JJ, Purandare N, Bagal B (2021). Bone marrow biopsy in PCNSL: Relevant or redundant? Neuro Oncology. 23(12):2117-2118. PMID: 34596688.
- Kapoor J, Khushoo V, Garg A, Naim F, Bhatia N, Folbs B, Mehta P, Ahmed R, Agrawal N, Bhurani D, Mirgh SP (2021). An "impossible" harvest-GCSF-induced immune thrombocytopenia in an autologous stem cell transplant recipient with multiple myeloma. Bone Marrow Transplantation. PMID: 33686246
- Mahantshetty U, Gurram L, Bushra S, Ghadi Y, A D, Paul J, Hande V, Chopra S, Ghosh J, Ts S, Popat P, Sable N, Maheswari A, Gupta S (2021). Single application multi-fractionated image guided adaptive High Dose Rate Brachytherapy for Cervical Cancer- Dosimetric & Clinical Outcomes. International Journal of Radiation Oncology Biology and Physics. 111(3):826-834. PMID: 34146636
- Menon N, Patil V, Noronha V, Joshi A, Bhattacharjee A, Satam B, Mathrudev V, Ghosh Laskar S, Prabhash K (2021). Quality of life in patients with locally advanced head and neck cancer treated with concurrent chemoradiation with cisplatin and nimotuzumab versus cisplatin alone – Additional data from a phase 3 trial, Oral Oncology. 122: 105517. PMID: 34560383
- Mittal R, Murthy V, Krishnatry R, Maitre P (2021). Recommendations and clinical validation of inguinal Clinical Target Volume (CTV) delineation in Penile cancer. International ournal Radiation Oncology Biology and Physics. 111(3):741-753. PMID: 34174355
- Mittra I, Mishra GA, Dikshit RP, Gupta S, Kulkarni VY, Shaikh HKA, Shastri SS, Hawaldar R, Gupta S, Pramesh CS, Badwe RA (2021). Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai. British Medical Journal. 372: n256. PMID: 33627312
- Murthy V, Maitre P (2021). A nodal risk cutoff for whole pelvic radiotherapy for prostate cancer? Lancet Oncology. 22(11):e467. PMID: 34735809
- Murthy V, Maitre P, Kannan S, Panigrahi G, Krishnatry R, Bakshi G, Prakash G, Pal M, Menon S, Phurailatpam R, Mokal S, Chaurasiya D, Popat P, Sable N, Agarwal A, Rangarajan V, Joshi A, Noronha V, Prabhash K, Mahantshetty U (2021). Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial. Journal of Clinical Oncology. 39(11):1234-1242. PMID: 33497252
- Patil VM, Singhai P, Noronha V, Bhattacharjee A, Deodhar J, Salins N, Joshi A, Menon NS, Abhyankar A, Khake A, Dhumal SB, Tambe R, Muckaden MA, Prabhash K (2021). Effect of early palliative care on quality of life of advanced head and neck cancer patients: A phase III Trial. Journal of National Cancer Institute. 113(9):1228-1237.PMID: 33606023
- Patkar N, Kakirde C, Shaikh AF, Salve R, Bhanshe P, Chatterjee G, Rajpal S, Joshi S, Chaudhary S, Kodgule R, Ghoghale S, Deshpande N, Shetty D, Khizer SH, Jain H, Bagal B, Menon H, Khattry N, Sengar M, Tembhare P, Subramanian P, Gujral S (2021). Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML). Leukemia. 35(5):1392-1404. PMID: 33558666.
- Pramesh CS, Babu GR, Basu J, Bhushan I, Booth CM, Chinnaswamy G, Guleria R, Kalantri SP, Kang G, Mohan P, Mor N, Pai M, Prakash M, Rupali P, Sampathkumar P, Sengar M, Sullivan R, Ranganathan P (2021). Choosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians. Nature Medicine. 27(8):1324-1327. PMID: 34226738.
- Punatar S, Kalantri SA, Chichra A, Agrawal AK, Nayak L, Bonda A, Gokarn A, Bagal B, Mathew L, Kannan S, Khattry N (2021). Pre-transplant use of tyrosine kinase inhibitors and transplant associated thrombotic microangiopathy - a single centre analysis of incidence, risk factors and outcomes. Bone Marrow Transplantation. 1558- 1562. PMID: 33514924
- Ranganathan P, Sengar M, Chinnaswamy G, Agrawal G, Arumugham R, Bhatt R, Bilimagga R, Chakrabarti J, Chandrasekharan A, Chaturvedi HK, Choudhrie R, Dandekar M, Das A, Goel V, Harris C, Hegde SK, Hulikal N, Joseph D, Kantharia R, Khan A, Kharde R, Khattry N, Lone MM, Mahantshetty U, Malhotra H, Menon H, Mishra D, Nair RA, Pandya SJ, Patni N, Pautu J, Pavamani S, Pradhan S, Thammineedi SR, Selvaluxmy G, Sharan K, Sharma BK, Sharma J, Singh S, Srungavarapu GC, Subramaniam R, Toprani R, Raman RV, Badwe RA, Pramesh CS (2021); National Cancer Grid of India. Impact of COVID-19 on cancer care in India: a cohort study. Lancet Oncology. 22(7):970-976. PMID: 34051879.
- Singhavi H, Khare N, Singh A, Khandelwal A, Kannan S, Patil A, Mittra I, Chaturvedi P (2021). Impact of pre-operative serum C-reactive protein and cell-free chromatin levels on tumor aggressiveness and survival outcome in oral cavity squamous cell carcinoma. Oral Oncology. 114: 105078. PMID: 33183996
- Solanki SL, Pandrowala S, Nayak A, Bhandare M, Ambulkar RP, Shrikhande SV (2021). Artificial intelligence in perioperative management of major gastrointestinal surgeries. World Journal of Gastroenterology. 27(21):2758-2770. PMID: 34135552
- Srinivasan S, Gurram L, Johny C, Chopra S, Dheera A, Baheti A, Popat P, Sable N, Rangarajan V, Mahantshetty U (2021). Validation and applicability of para-aortic lymph nodal contouring atlas in cervical cancer. Radiotherapy and Oncology. 165:32-36. PMID: 34710510
- Starr N, Capo-Chichi N, Moore J, Shreckengost CH, Fernandez K, Ambulkar R, Varallo JE, Ademuyiwa AO, Krouch S, Rana PS, Ingabire JA, Weiser TG, Mammo TN, Evans FM (2021). Perioperative provider safety in low and middle-income countries during the COVID-19 pandemic: a call for renewed investments in resources and training. Annals of Surgery. 274(6):e525-e627. PMID: 34225300.
- Yeole U, Shetty P, Singh V, Moiyadi A. (2021) Pattern of use of intraoperative ultrasound in surgery for brain tumors influences outcomes in glial tumors. British Journal of Neurosurgery. PMID: 34927516.
- Bandekar M, Maurya DK, Sharma D, Checker R, Gota V, Mishra N, Sandur SK (2020). Xenogeneic transplantation of Human WJ-MSCs rescues mice from acute radiation syndrome via Nrf2 dependent regeneration of damaged tissues. American Journal of Trasplantation. PMID: 32040239
- Chopra S, Engineer R, Shah S, Shukla R, Dora T, Gupta P, Paul SN, Popat P, Swamidas J, Mahantshetty U, Varghese L, Gupta S, Rangrajan V, Shrivastava S. MRI and PET Guided Interstitial Brachytherapy for post-surgical vaginal recurrences of cervical cancer: Results of phase II study. International Journal of Radiation Oncology Biology Physics. 106(2): 310-319, 2020. PMID: 31682968
- Gupta S, Aitken J, Bartels U, Bhakta N, Bucurenci M, Brierley JD, De Camargo B, Chokunonga E, Clymer J, Coza D, Fraser C, Fuentes-Alabi S, Gatta G, Gross T, Jakab Z, Kohler B, Kutluk T, Moreno F, Nakata K, Nur S, Parkin DM, Penberthy L, Pole J, Poynter JN, Pritchard-Jones K, Ramirez O, Renner L, Steliarova-Foucher E, Sullivan M, Swaminathan R, Van Eycken L, Vora T, Frazier AL. Development of paediatric non-stage prognosticator guidelines for population-based cancer registries and updates to the 2014 Toronto Paediatric Cancer Stage Guidelines. Lancet Oncology. 21(9): e444-e451. PMID: 32888473
- Gupta T, Chatterjee A, Patil V (2020). Extended adjuvant temozolomide in newly-diagnosed glioblastoma: is more less? Neuro-Oncology. 22(12): 1887-1888. PMID: 32777076
- Gillessen S, Attard G, Beer TM, Beltran H, Bjartell A, Bossi A, Briganti A, Bristow RG, Chi KN, Clarke N, Davis ID, de Bono J, Drake CG, Duran I, Eeles R, Efstathiou E, Evans CP, Fanti S, Feng FY, Fizazi K, Frydenberg M, Gleave M, Halabi S, Heidenreich A, Heinrich D, Higano CTS, Hofman MS, Hussain M, James N, Kanesvaran R, Kantoff P, Khauli RB, Leibowitz R, Logothetis C, Maluf F, Millman R, Morgans AK, Morris MJ, Mottet N, Mrabti H, Murphy DG, Murthy V, Oh WK, Ost P, O'Sullivan JM, Padhani AR, Parker C, Poon DMC, Pritchard CC, Reiter RE, Roach M, Rubin M, Ryan CJ, Saad F, Sade JP, Sartor O, Scher HI, Shore N, Small E, Smith M, Soule H, Sternberg CN, Steuber T, Suzuki H, Sweeney C, Sydes MR, Taplin ME, Tombal B, Türkeri L, van Oort I, Zapatero A, Omlin A (2020). Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. European Urology. 77(4): 508-547. PMID: 32001144
- Goda JS, Dutta D, Krishna U, Goswami S, Gupta T, Kothavade V, Kannan S, Maitre M, Bano N, Jalali R (2020). Hippocampal radiotherapy dose-constraints for predicting long-term neurocognitive outcomes: Mature data from a prospective trial in young patients with brain tumors. Neuro-Oncology. PMID: 32227185
- Murthy V, Maitre P, Bhatia J, Kannan S, Krishnatry R, Prakash G, Bakshi G, Pal M, Menon S, Mahantshetty U (2020). Late toxicity and quality of life with prostate only or whole pelvic radiation therapy in high risk prostate cancer (POP-RT): A randomised trial. Radiotherapy and Oncology. 145: 71-80. PMID: 31923712
- Noronha V, Patil VM, Joshi A, Menon N, Chougule A, Mahajan A, Janu A, Purandare N, Kumar R, More S, Goud S, Kadam N, Daware N, Bhattacharjee A, Shah S, Yadav A, Trivedi V, Behel V, Dutt A, Banavali SD, Prabhash K. Gefitinib Versus gefitinib plus pemetrexed and carboplatin chemotherapy in EGFR-Mutated lung cancer. Journal of Clinical Oncology. 38(2): 124-136. PMID: 31411950
- Noronha V, Bhattacharjee A, Patil VM, Joshi A, Menon N, Shah S, Kannan S, Mukadam SA, Maske K, Ishi S, Prabhash K (2020). Aprepitant for cough suppression in advanced lung cancer: A randomized trial. Chest. 157(6): 1647-1655 PMID: 31958446
- Ostwal V, Kapoor A , Mandavkar S, Chavan N, Gupta T, Mirani J, Saklani A, Desouza A, Shrinivasan K, Nashikkar C, Gupta S, Ramaswamy A (2020). Effect of a Structured Teaching Module Including Intensive Prophylactic Measures on Reducing the Incidence of Capecitabine-Induced Hand-Foot Syndrome: Results of a Prospective Randomized Phase III Study. Oncologist. 25(12): e1886-e1892. PMID: 32717127
- Park YH, Senkus-Konefka E, Im SA, Pentheroudakis G, Saji S, Gupta S, Iwata H, Mastura MY, Dent R, Lu YS, Yin Y, Smruti BK, Toyama T, Malwinder S, Lee SC, Tseng LM, Kim JH, Kim TY, Suh KJ, Cardoso F, Yoshino T, Douillard JY (2020). Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS. Annals of Oncology. 31(4):451-469. PMID: 32081575
- Patkar N, Bhanshe P, Rajpal S, Joshi S, Chaudhary S, Chatterjee G, Tembhare P, Dhamne C, Prasad M, Moulik NR, Shetty D, Gokarn A, Bonda A, Nayak L, Punatkar S, Bagal B, Sengar M, Narula G, Khattry N, Banavali S, Subramanian PG, Gujral S (2020). NARASIMHA: Novel assay based on targeted RNA sequencing to identify ChiMeric gene fusions in hematological malignancies. Blood Cancer Journal. 10(5): 50. PMID: 32372024
- Raut A, Chopra S, Mittal P, Patil G, Mahantshetty U, Gurram L, Swamidas J, Ghosh J, Gulia S, Popat P, Deodhar K, Maheshwari A, Gupta S (2020). FIGO classification 2018: Validation study in patients with locally advanced cervix cancer treated with chemo-radiation. International Journal of Radiation Oncology, Biology Physics. PMID: 32681859
- Swamidas J, Kirisits C, De Brabandere M, Hellebust TP, Siebert FA, Tanderup K (2020). Image registration, contour propagation and dose accumulation of external beam and brachytherapy in gynecological radiotherapy. Radiotherapy Oncology. 143: 1-11. PMID: 31564555
- Berger T, Seppenwoolde Y, Pötter R, Assenholt MS, Lindegaard SJ, Nout R, Leeuw A, Jürgenliemk-Schulz I, Tee Tan L, Georg D, Kirisits C, Dumas I, Nesvacil N, Swamidas J, Hudej R, Lowe G, Hellebust TP, Menon G, Fokdal L, Tanderup K (2019) - Importance of technique, target selection, contouring, dose prescription and dose-planning in external beam radiotherapy for cervix cancer: evolution of practice from EMBRACE-I to II. International Journal of Radiation Oncology, Biology, Physics. 104(4): 885-894. PMID: 30904706
- Biswas NK, Das C, Das S, Maitra A, Nair S, Gupta T, D'Cruz AK, Sarin R, Majumder PP (2019) - Lymph node metastasis in oral cancer is strongly associated with chromosomal instability and DNA repair defects. International Journal of Cancer. 145(9): 2568-2579. PMID: 30924133
- Chopra S, Deodhar K, Pai V, Pant S, Rathod N, Goda JS, Sudhalkar N, Pandey P, Waghmare S, Engineer R, Mahantshetty U, Ghosh J, Gupta S, Shrivastava S. Cancer Stem Cells, CD44, and Outcomes Following Chemoradiation in Locally Advanced Cervical Cancer: Results From a Prospective Study. International Journal of Radiation Oncology, Biology , Physics. 103(1): 161-168. PMID: 30213750
- Dasgupta A, Gupta T, Pungavkar S, Shirsat N, Epari S, Chinnaswamy G, Mahajan A, Janu A, Moiyadi A, Kannan S, Krishnatry R, Goda JS, Jalali R (2019) - Nomograms based on pre-operative multi-parametric magnetic resonance imaging for prediction of molecular subgrouping in medulloblastoma: Results from a radiogenomics study of 111 Patients. Neuro- Oncology. 21(1): 115-124. PMID: 29846693
- Gandhi KA, Goda JS, Gandhi VV, Sadanpurwala A, Jain VK, Joshi K, Epari S, Rane S, Mohanty B, Chaudhari P, Kembhavi S, Kunwar A, Gota V, Priyadarsini KI (2019) - Oral administration of 3,3'-diselenodipropionic acid prevents thoracic radiation induced pneumonitis in mice by suppressing NF-kB/IL-17/G-CSF/neutrophil axis. Free Radical Biology and Medicine.145: 8-19, PMID: 31521664
- Jalali R, Goda JS (2019) - Proton beam therapy in pediatric brain tumor patients: Improved radiation delivery techniques improve neurocognitive outcomes. Neuro- Oncology. 21(7): 830-831. PMID: 31081892
- Jha P, Kumar D, Dikshit R, Budukh A, Begum R, Sati P, Kolpak P, Wen R, Raithatha SJ, Shah U, Li ZR, Aleksandrowicz L, Shah P, Piyasena K, McCormick TH, Gelband H, Clark SJ (2019) - Automated versus physician assignment of cause of death for verbal autopsies: Randomized trial of 9374 deaths in 117 villages in India. BMC Medicine. 17(1): 116. PMID: 31242925
- Mahantshetty U, Sturdza A, Pusha Naga CH, Berger D, Fortin I, Motisi L, Schmid MP, Aravindakshan D, Ghdi Y, Swamidas JV, Chopra S, Gurram L, Nescacil N, Kirisits C, Richard Pötter (2019) - Vienna-II ring applicator for distal parametrial/pelvic wall disease in cervical cancer brachytherapy: An experience from two institutions: Clinical feasibility and outcome. Radiotherapy and Oncology. 141: 123-129, 2019. PMID: 31495516
- Murthy V (2019) - International consensus for advanced bladder cancer: An opportunity between the lines. Annals of Oncology. 30(11): 1688-1690. PMID: 31750878
- Murthy V, Johnny C, Huddart R (2019) - Positron Emission Tomography-positive post-chemotherapy seminoma masses: Time to reevaluate the role of radiotherapy? Journal of Clinical Oncology. 37(11): 937-938. PMID: 30811289
- Page EC, Bancroft EK, Brook MN, Assel M, Hassan Al Battat M, Thomas S, Taylor N, Chamberlain A, Pope J, Raghallaigh HN, Evans DG, Rothwell J, Mahle L, Grindedal EMM, James P, Mascarenhas L, McKinley J, Side L, Thomas T, van Asperen C, Vasen H, Kiemeney LA, Ringelberg J, Jensen TD, Osther PJS, Helfand BT, Genova E, Oldenburg RA, Cybulski C, Wokolorczyk D, Ong KR, Huber C, Lam J, Taylor L, Salinas M, Feliubadaló L, Oosterwijk JC, van Zelst-Stams W, Cook J, Rosario DJ, Domchek S, Powers J, Buys S, O'Toole K, Ausems MGEM, Schmutzler RK), Rhiem K, Izatt L, Tripathi V, Teixeira MR, Cardoso M, Foulkes WD, Aprikian A, van Randeraad H, Davidson R, Longmuir M, Ruijs MWG, Helderman van den Enden ATJM, Adank M, Williams R, Andrews L, Murphy DG, Halliday D, Walker L, Liljegren A, Carlsson S, Azzabi A, Jobson I, Morton C, Shackleton K, Snape K, Hanson H, Harris M, Tischkowitz M, Taylor A, Kirk J, Susman R, Chen-Shtoyerman R, Spigelman A, Pachter N, Ahmed M, Ramon Y Cajal T, Zgajnar J, Brewer C, Gadea N, Brady AF, van Os T, Gallagher D, Johannsson O, Donaldson A, Barwell J, Nicolai N, Friedman E, Obeid E, Greenhalgh L, Murthy V, Copakova L, Saya S, McGrath J, Cooke P, Rønlund K, Richardson K, Henderson A, Teo SH, Arun B, Kast K, Dias A, Aaronson NK, Ardern-Jones A, Bangma CH, Castro E, Dearnaley D, Eccles DM, Tricker K, Eyfjord J, Falconer A, Foster C, Gronberg H, Hamdy FC, Stefansdottir V, Khoo V, Lindeman GJ, Lubinski J, Axcrona K, Mikropoulos C, Mitra A, Moynihan C, Rennert G, Suri M, Wilson P, Dudderidge T, IMPACT Study Collaborators, Offman J, Kote-Jarai Z, Vickers A, Lilja H, Eeles RA (2019) - Interim results from the IMPACT study: Evidence for prostate-specific antigen screening in BRCA2 mutation carriers. European Urology. 76(6): 831-842. PMID: 31537406
- Patil VM, Noronha V, Joshi A, Dhumal S, Mahimkar M, Bhattacharjee A, Gota V, Pandey M, Menon N, Mahajan A, Sable N, Kumar S, Nawale K, Mukadam S, Solanki B, Das S, Simha V, Abraham G, Chandrasekharan A, Talreja V, D’souza H, Srinivas S, Kashyap L, Banavali S, Prabhash K (2019) - Phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early-failure oral cancer. Journal of Clinical Oncology. 37(32): 3032-3041. PMID: 31539316
- Patkar N, Shaikh AF, Kakirde C, Nathany S, Ramesh H, Bhanshe P, Joshi S, Chaudhary S, Kannan S, Khizer SH, Chatterjee G, Tembhare P, Shetty D, Gokarn A, Punatkar S, Bonda A, Nayak L, Jain H, Khattry N, Bagal B, Sengar M, Gujral S, Subramanian P (2019) - A novel machine-learning-derived genetic score correlates with measurable residual disease and is highly predictive of outcome in acute myeloid leukemia with mutated NPM1. Blood Cancer Journal. 9(10): 79, PMID: 31575857
- Gupta S, Maheshwari A, Parab P, Mahantshetty U, Hawaldar R, Sastri Chopra S, Kerkar R, Engineer R, Tongaonkar H, Ghosh J, Gulia S, Kumar N, Shylasree TS, Gawade R, Kembhavi Y, Gaikar M, Menon S, Thakur M, Shrivastava S, Badwe R (2018). Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage IB2, IIA, or IIB squamous cervical cancer: A randomized controlled trial. Journal of Clinical Oncology. 36(16): 1548-1555. PMID: 29432076
- Kirolikar S, Prasannan P, Raghuram GV, Pancholi N, Saha T, Tidke P, Chaudhari P, Shaikh A, Rane B, Pandey R, Wani H, Khare NK, Siddiqui S, D'souza J, Prasad R, Shinde S, Parab S, Nair NK, Pal K, Mittra I (2018). Prevention of radiation-induced bystander effects by agents that inactivate cell-free chromatin released from irradiated dying cells. Cell Death and Disease. 9(12): 1142. PMID: 30442925
- Mahantshetty U, Naga P, Khadanga CR, Gudi S, Chopra S, Gurram L, Jamema S, Ghadi Y, Shrivastava S (2018). A prospective comparison of computerized-tomography (CT) based with trans-rectal-ultrasonography (TRUS) assistance and magnetic-resonance imaging (MRI) based target-volume definition during image guided adaptive brachytherapy for cervical cancers. International Journal of Radiation Oncology, Biology, Physics. 102(5): 1448-1456. PMID: 30146092
- Mikropoulos C, Selkirk CGH, Saya S, Bancroft E, Vertosick E, Dadaev T, Brendler C, Page E, Dias A, Evans DG, Rothwell J, Maehle L, Axcrona K, Richardson K, Eccles D, Jensen T, Osther PJ, van Asperen CJ, Vasen H, Kiemeney LA, Ringelberg J, Cybulski C, Wokolorczyk D, Hart R, Glover W, Lam J, Taylor L, Salinas M, Feliubadaló L, Oldenburg R, Cremers R, Verhaegh G, van Zelst-Stams WA, Oosterwijk JC, Cook J, Rosario DJ, Buys SS, Conner T, Domchek S, Powers J, Ausems MG, Teixeira MR, Maia S, Izatt L, Schmutzler R, Rhiem K, Foulkes WD, Boshari T, Davidson R, Ruijs M, Helderman-van den Enden AT, Andrews L, Walker L, Snape K, Henderson A, Jobson I, Lindeman GJ, Liljegren A, Harris M, Adank MA, Kirk J, Taylor A, Susman R, Chen-Shtoyerman R, Pachter N, Spigelman A, Side L, Zgajnar J, Mora J, Brewer C, Gadea N, Brady AF, Gallagher D, van Os T, Donaldson A, Stefansdottir V, Barwell J, James PA, Murphy D, Friedman E, Nicolai N, Greenhalgh L, Obeid E, Murthy V, Copakova L, McGrath J, Teo SH, Strom S, Kast K, Leongamornlert DA, Chamberlain A, Pope J, Newlin AC, Aaronson N, Ardern-Jones A, Bangma C, Castro E, Dearnaley D, Eyfjord J, Falconer A, Foster CS, Gronberg H, Hamdy FC, Johannsson O, Khoo V, Lubinski J, Grindedal EM, McKinley J, Shackleton K, Mitra AV, Moynihan C, Rennert G, Suri M, Tricker K; IMPACT study collaborators, Moss S, Kote-Jarai Z, Vickers A, Lilja H, Helfand BT, Eeles RA (2018). Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition. British Journal of Cancer. 118(2):266-276. PMID: 29301143
- Ng AK, Yahalom J, Goda JS, Constine LS, Pinnix CC, Kelsey CR, Hoppe B, Oguchi M, Suh CO, Wirth A, Qi S, Davies A, Moskowitz CH, Laskar S, Li Y, Mauch PM, Specht L, Illidge T. Role of radiation therapy in patients With relapsed/refractory diffuse large B-cell lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group. International Journal of Radiation Oncology, Biology, Physics. 100(3): 652-669, 2018. PMID: 29413279
- Noronha V, Joshi A, Patil VM, Agarwal J, Ghosh-Laskar S, Budrukkar A, Murthy V, Gupta T, D'Cruz AK, Banavali S, Pai PS, Chaturvedi P, Chaukar D, Pande N, Chandrasekharan A, Talreja V, Vallathol DH, Mathrudev V, Manjrekar A, Maske K, Bhelekar AS, Nawale K, Kannan S, Gota V, Bhattacharjee A, Kane S, Juvekar SL, Prabhash K (2018). Once-a-Week versus Once-every-3-Weeks cisplatin chemoradiation for locally advanced head and neck Cancer: A phase III randomized noninferiority trial. Journal of Clinical Oncology. 10; 36(11): 1064-1072. PMID: 29220295
- Sargos P, Baumann BC, Eapen L, Christodouleas J, Bahl A, Murthy V, Efstathiou J, Fonteyne V, Ballas L, Zaghloul M, Roubaud G, Orré M, Larré S (2018). Risk factors for loco-regional recurrence after radical cystectomy of muscle-invasive bladder cancer: A systematic-review and framework for adjuvant radiotherapy. Cancer Treatment Reviews. 70: 88-97. PMID: 30125800
- Tsang RW, Campbell BA, Goda JS, Kelsey CR, Kirova YM, Parikh RR, Ng AK, Ricardi U, Suh C-Ok, Mauch PM, Specht L, Yahalom J. Radiation therapy for solitary plasmacytoma and multiple myeloma: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG). International Journal of Radiation Oncology, Biology, Physics. 101(4): 794-808, 2018. PMID: 29976492
- Gupta S, Mukherjee S, Syed P, Pandala NG, Choudhary S, Singh VA, Singh N, Zhu H, Epari S, Noronha SB, Moiyadi A, Srivastava S (2017). Evaluation of autoantibody signatures in meningioma patients using human proteome arrays. Oncotarget. 8(35): 58443-58456. PMID: 28454087
- Mahantshetty U, Krishanty R, Hande V, Jamema S, Ghadi Y, Engineer R, Chopra S, Naidu L, Deshpande D, Shrivastava S. Magnetic resonance image guided adaptive brachytherapy in locally advanced cervical cancer: An experience from a tertiary cancer centre in a low-middle income country setting. International Journal of Radiation Oncology, Biology, Physics. 99(3): 608-617
- Mittra I, Pal K, Pancholi N, Shaikh A, Rane B, Tidke P, Kirolikar S, Khare NK, Agrawal K, Nagare H, Nair NK (2017). Prevention of chemotherapy toxicity by agents that neutralize or degrade cell-free chromatin. Annals of Oncology. 28(9): 2119-2127. PMID: 28911066
- Prabhu S, Goda JS, Mutalik S, Mohanty BS, Chaudhari P, Rai S, Udupa N, Rao BSS (2017). A polymeric temozolomide nanocomposite against orthotopic glioblastoma xenograft: Tumor-specific homing directed by nestin. Nanoscale. 9(30): 10919-10932. PMID: 28731079
- Regan MM, Walley BA, Francis PA, Fleming GF, Láng I, Gómez HL, Colleoni M, Tondini C, Pinotti G, Salim M, Spazzapan S, Parmar V, Ruhstaller T, Abdi EA, Gelber RD, Coates AS, Goldhirsch A, Pagani O (2017). Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: An exploratory analysis of TEXT and SOFT. Annals of Oncology. 28(9): 2225-2232. PMID: 28911092
- Saha P, Regan MM, Pagani O, Francis PA, Walley BA, Ribi K, Bernhard J, Luo W, Gómez HL, Burstein HJ, Parmar V, Torres R, Stewart J, Bellet M, Perelló A, Dane F, Moreira A, Vorobiof D, Nottage M, Price KN, Coates AS, Goldhirsch A, Gelber RD, Colleoni M, Fleming GF (2017). Treatment efficacy, adherence, and quality of life among women younger than 35 years in the International Breast Cancer Study Group TEXT and SOFT adjuvant endocrine therapy trials. Journal of Clinical Oncology. 35(27): 3113-3122, 2017.PMID: 28654365
- Ballinger ML, Goode DL, Ray-Coquard I, James PA, Mitchell G, Niedermayr E, Puri A, Schiffman JD, Dite GS, Cipponi A, Maki RG, Brohl AS, Myklebost O, Stratford EW, Lorenz S, Ahn S-M, Ahn J-H, Kim JE, Shanley S, Beshay V, Randall RL, Judson I, Seddon B, Campbell IG, Young M-A, Sarin R, Blay J-Y, Seán, O'Donoghue I, Thomas DM (2016). Monogenic and polygenic determinants of sarcoma risk: An international genetic study. Lancet Oncol. 17(9): 1261-1271, 2016. PMID: 27498913
- Kannan A, Wells RB, Sivakumar S, Komatsu S, Singh KP, Samten B, Philley JV, Sauter ER, Ikebe M, Idell S, Gupta S, Dasgupta S (2016). Mitochondrial Reprogramming Regulates Breast Cancer Progression. Clinical Cancer Research. 22(13): 3348-60. PMID: 26888829.
- Nagrani R, Mhatre S, Rajaraman P, Soerjomataram I, Boffeta P, Gupta S, Parmar V, Badwe R, Dikshit R (2016). Central obesity increases risk of breast cancer irrespective of menopausal and hormonal receptor status in women of South Asian Ethnicity. European Journal of Cancer. 66: 153-161. PMID: 27573429
- Badwe R, Hawaldar R, Nair N, Kaushik R, Parmar V, Siddique S, Budrukkar A, Mittra I, Gupta S (2015). Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: An open-label randomised controlled trial. Lancet Oncology. 16:1380-1388. PMID: 26363985
- D'Cruz AK, Vaish R, Kapre N, Dandekar M, Gupta S, Hawaldar R, Agarwal JP, Pantvaidya G, Chaukar D, Deshmukh A, Kane S, Arya S, Ghosh-Laskar S, Chaturvedi P, Pai P, Nair S, Nair D, Badwe R (2015). Head and Neck Disease Management Group. Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer. New England Journal of Medicine. 373: 521-529. PMID: 26027881
- Suryavanshi S, Sharma D, Checker R, Thoh M, Gota V, Sandur SK, Sainis KB (2015). Amelioration of radiation induced hematopoietic syndrome by an antioxidant chlorophyllin through increased stem cell activity and modulation of haematopoiesis . Free Radical Biology and Medicine. 85: 56-70.PMID: 25872101
- Syed P, Gupta S, Choudhary S, Pandala NG, Atak A, Richharia A, Kp M, Zhu H, Epari S, Noronha SB, Moiyadi A, Srivastava S (2015). Autoantibody profiling of glioma serumsamples to identify biomarkers using human proteome arrays. Scientific Reports. PMID: 26370624
- Venkitaraman R, Lorente D, Murthy V, Thomas K, Parker L, Ahiabor R, Dearnaley D, Huddart R, De Bono J, Parker C (2015). A Randomised Phase 2 Trial of Dexamethasone Versus Prednisolone in Castration-resistant Prostate Cancer.European Urology. 67(4): 673-679. PMID: 25457497
